Guided Therapeutics (GTHP) Current Deferred Tax Assets (2016)
Guided Therapeutics' Current Deferred Tax Assets history spans 5 years, with the latest figure at $795000.0 for Q4 2016.
- On a quarterly basis, Current Deferred Tax Assets rose 27.0% to $795000.0 in Q4 2016 year-over-year; TTM through Dec 2016 was $795000.0, a 27.0% increase, with the full-year FY2016 number at $795000.0, up 27.0% from a year prior.
- Current Deferred Tax Assets hit $795000.0 in Q4 2016 for Guided Therapeutics, up from $626000.0 in the prior quarter.
- Over the last five years, Current Deferred Tax Assets for GTHP hit a ceiling of $795000.0 in Q4 2016 and a floor of $277000.0 in Q4 2012.
- Historically, Current Deferred Tax Assets has averaged $490200.0 across 5 years, with a median of $466000.0 in 2014.
- Biggest five-year swings in Current Deferred Tax Assets: increased 3.61% in 2013 and later soared 62.37% in 2014.
- Tracing GTHP's Current Deferred Tax Assets over 5 years: stood at $277000.0 in 2012, then rose by 3.61% to $287000.0 in 2013, then soared by 62.37% to $466000.0 in 2014, then skyrocketed by 34.33% to $626000.0 in 2015, then grew by 27.0% to $795000.0 in 2016.
- Business Quant data shows Current Deferred Tax Assets for GTHP at $795000.0 in Q4 2016, $626000.0 in Q4 2015, and $466000.0 in Q4 2014.